EVIDENCE CONFIRMS LINK BETWEEN SOY PROTEIN CONSUMPTION AND LOWERING OF CHOLESTEROL STUDY SHOWS THAT SOY PROTEIN REDUCES CHOLESTEROL

Buying Power, Inc. is committed to helping you maximize your health and well-being. All of us want to enjoy vigorous, healthy lives. Sometimes it's difficult to eat a fully balanced diet and even those that do may require additional nutrients for optimum health.

1-800-577-1826

EVIDENCE CONFIRMS LINK BETWEEN SOY PROTEIN CONSUMPTION AND LOWERING OF CHOLESTEROL STUDY SHOWS THAT SOY PROTEIN REDUCES CHOLESTEROL

Story Filed: Wednesday, September 29, 1999 2:21 PM EST

ST. LOUIS, Sep 29, 1999 /PRNewswire via COMTEX/ -- Researchers at Wake Forest University Baptist Medical Center today published the results of a carefully designed clinical trial supporting the cardiovascular health benefits of soy protein. The study is further evidence in the mounting case being made by researchers surrounding the heart-health benefits of soy protein with naturally occurring isoflavones.

The nine-week study, conducted by John R. Crouse III, M.D., and co-sponsored by Protein Technologies International of St. Louis, MO, looked at two different groups of participants -- those with moderately high levels (greater than 164 mg/dl) of LDL (or "bad") cholesterol, and those with close-to-normal LDL levels. Reporting the results of the study in the September 29 issue of the Archives of Internal Medicine, Crouse notes that the study results "demonstrate that isolated soy protein with isoflavones lowers cholesterol ... particularly in individuals with elevated plasma concentrations of LDL cholesterol."

Crouse's study also determined that consumption of soy protein with naturally occurring isoflavones does not adversely affect HDL, or "good" cholesterol levels.

Leaders in the soy industry, such as Protein Technologies International (PTI), were encouraged by the results of the study, which offers further support to the soy protein health claim petition currently under review by the U.S. Food & Drug Administration. If approved, the health claim rule -- requested by PTI in 1998 -- would allow food manufacturers to label products containing a FDA-determined amount of soy protein as being heart-healthy.

"The results of this study offer encouraging support to the health claim petition, as well as to health-conscious American consumers," notes Ed Coco, Co-President, PTI. "The hard science Dr. Crouse and his team of researchers have presented in support of the importance of soy protein as a tool in battling heart disease is welcome news for the millions of Americans concerned with battling cardiovascular disease -- the number one killer in the United States."

In addition to support from PTI, the study was also supported by the General Clinical Research Center at Wake Forest, which is supported by the National Institute of Health. Other researchers involved in the study included Timothy Morgan, Ph.D., James G. Terry, M.S., Julie Ellis, M.P.H., Mara Vitolins, Dr. P.H., and Gregory Burke, M.D., M.S.

Protein Technologies International, a DuPont Business, is a leading researcher, manufacturer and marketer of high-quality soy protein and soy fiber ingredients. It supplies these ingredients to food manufacturers worldwide. Headquartered in St. Louis, MO, the company has more than 1,200 employees in 35 countries.


CONTACT:       Georgina Sikorski of Protein Technologies International,

314-982-3848; or Justin Shaw, 212-527-8978, or Lesley Stewart, 212-527-8847, both of The Rowland Company, for Protein Technologies International

GEOGRAPHY:     Missouri

INDUSTRY CODE: HEA MTC FOD

Home